ReviewEndocrine-related cancer2026

PRRT for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Virginia Corbett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.